Precision Optics Corporation (POCI): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Precision Optics (POCI) maintains stable liquidity, where the supply of endoscope components guarantees the cash flow necessary to cover capital expenditures. This chart of EV/EBITDA history on GURU.Markets shows 0.00, linking finances to the development of robotic surgery alliances aimed at increasing surgical precision. Precision Optics (POCI) also curates the micro-visualization environment, serving as a critical technical ally to physicians through the implementation of innovative sensors.

Precision Optics Corp - POCI Company Value to EBITDA (period 11/23/2025 - 11/10/2026)

Metric breakdowns and analytics for poci.com (POCI)

- current price and projected stock value:

Stock Price Precision Optics Corporation|POCI - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value POCI|POCI - Business Value

- book value of equity indicators:

Book Value per Share Precision Optics|POCI - Total Stockholders' Equity|Market Value to Book Value Ratio poci.com|POCI - Company Assets

- company total debt and liquidity indicators:

- financial results and valuation multiples details:

POCI - Company Net Income|Projected Future Earnings Precision Optics|POCI - Price to Earnings Multiple|Forward P/E Multiple Precision Optics Corporation|POCI - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple POCI|POCI - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Precision Optics|POCI - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months poci.com|POCI - Earnings per share growth in current year|Expected earnings per share growth for next year Precision Optics

Comprehensive company analysis:Precision Optics Corporation, Inc. (POCI)

Manufactured products of Precision Optics Corporation

Stable B2B contracts for micro-optics production at Precision Optics (POCI) make the EV/EBITDA multiple chart on GURU.Markets a key tool for analyzing long-term profitability. This indicator compares the total enterprise value (market capitalization and debt) with operating profit before interest, taxes, depreciation, and amortization, allowing investors to filter out market noise and determine the real value of the company's hard assets.

Key competitors

EV/EBITDA Multiple SYK (Stryker Inc)|EV/EBITDA Multiple Medtronic Corp MDT|PHG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SNN (smith-nephew.com) - Enterprise Value to Operating Income Before Depreciation|HOLX: EV/EBITDA Multiple|Company Value to EBITDA Carlisle Companies Incorporated (CSL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Greatbatch|Company Value to EBITDA LivaNova Corp LIVN|Enterprise Value to EBITDA Ratio AHCO (AdaptHealth Corp.)|EV/EBITDA Multiple SS Innovations International, Inc. (SSII)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avanos Medical AVNS|Total Company Value to Operating Income Before Depreciation Ratio Shoulder Innovations, Inc. (SI)|VMD: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation INGN (Inogen, Inc.)|owletcare.com (OWLT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio quipthomemedical.com|PAVM (PAVmed, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Tivic Health Systems, Inc. TIVC|EV/EBITDA Multiple MOVE|Nuvo Group Ltd - Enterprise Value to Operating Income Before Depreciation